| 73475-3102-3 |
73475-3102 |
HUMAN PRESCRIPTION DRUG |
VYVGART Hytrulo |
efgartigimod alfa and hyaluronidase (human recombinant) |
INJECTION, SOLUTION |
SUBCUTANEOUS |
20230620 |
N/A |
BLA |
BLA761304 |
argenx US |
EFGARTIGIMOD ALFA; HYALURONIDASE (HUMAN RECOMBINANT) |
180 mg/mL; 2000 U/mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (73475-3102-3) / 5.6 mL in 1 VIAL, SINGLE-DOSE |
| 73475-1221-1 |
73475-1221 |
HUMAN PRESCRIPTION DRUG |
VYVGART Hytrulo |
efgartigimod alfa and hyaluronidase (human recombinant) |
INJECTION, SOLUTION |
SUBCUTANEOUS |
20250410 |
N/A |
BLA |
BLA761304 |
argenx US |
EFGARTIGIMOD ALFA; HYALURONIDASE (HUMAN RECOMBINANT) |
200 mg/mL; 2000 U/mL |
1 SYRINGE, GLASS in 1 CARTON (73475-1221-1) / 5 mL in 1 SYRINGE, GLASS |
| 73475-1221-4 |
73475-1221 |
HUMAN PRESCRIPTION DRUG |
VYVGART Hytrulo |
efgartigimod alfa and hyaluronidase (human recombinant) |
INJECTION, SOLUTION |
SUBCUTANEOUS |
20250410 |
N/A |
BLA |
BLA761304 |
argenx US |
EFGARTIGIMOD ALFA; HYALURONIDASE (HUMAN RECOMBINANT) |
200 mg/mL; 2000 U/mL |
4 SYRINGE, GLASS in 1 CARTON (73475-1221-4) / 5 mL in 1 SYRINGE, GLASS |